ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1833

The Vδ2 Subset of Γδt-Cells Are Present at Healthy Human Enthesis and Have Transcriptional and Functional Characteristics Consistent with a Capacity for IL- 17A Production in Response to IL-23

Richard Cuthbert1, Evangelos M. Fragkakis1, Charlie Bridgewood1, Robert Dunsmuir2, Abdulla Watad3, Abhay Rao2, Almas Khan2, Helena Marzo-Ortega4, Darren Newton5 and Dennis McGonagle1, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2Department of Spinal Surgery, National Health Service, Leeds, United Kingdom, 3Department of Internal Medicine 'B', Sheba Medical Center, Ramat Gan, Ramat Gan, Israel, 4NIHR LBRC, LTHT and LIRMM, University of Leeds, Leeds, United Kingdom, 5Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: innate immunity, pathogenesis and spondylarthritis, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: 4M088 ACR Abstract: Spondyloarthritis Incl PsA–Basic Science (1828–1833)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

Recent mouse studies of SpA pathogenesis have suggested that γδT-cells accumulate at entheseal regions in an IL-23 overexpression model and that these cells are responsible for the majority of local IL-17A production. Moreover a specific subset of γδT-cells (Vγ6) has been implicated in murine enthesitis and bone regeneration. This study aimed to examine the local distribution of γδT-cell subsets in normal human enthesis and identify which are most likely to participate in IL-23/17 axis driven inflammation.

Methods:

Human entheseal soft tissue (EST) and peri-entheseal bone (PEB) was harvested from normal spinous process in patients undergoing elective spinal orthopaedic procedures. Interspinous EST was dissected from PEB and enzymatically digested. Cell sorting was used to isolate γδT-cells expressing the Vδ1 or Vδ2 isoforms of the TCR receptor γδT-cells expressing other Vδ isoforms were also collected. Following isolation RNA was purified and analysed by TaqMan array. Healthy entheseal tissue and peripheral blood collected from patients with either PsA or AS was stimulated with phorbol 12-myristate 13-acetate (PMA)/ionomycin and intracellular IL-17A production was measured in T-cell subsets.

Results:

Healthy EST contained a similar proportion of γδ subsets, (37%Vδ1 and 57%Vδ2) as was observed in peripheral blood (28%Vδ1 and 63%Vδ2), PEB contained a higher proportion of the Vδ1 subset and a lower proportion of the Vδ2 subset (50% and 39% respectively). The Vδ2 subset expressed a high relative abundance of IL-23/17 pathway associated transcripts including IL-23R, RORC and CCR6 they also expressed high relative abundance of TGFb1 transcript, a cytokine associated with immunomodulation and tissue residency. Following PMA stimulation IL-17A was robustly detected in CD4+ T-cells and in γδT-cells was detected predominantly in the Vδ2 subset although some signal was also observed in Vδ1 cells.

Conclusion:

The Vδ2 subset of γδT-cells are present in entheseal tissues, their transcriptional profile and functional characteristics are consistent with IL-23 responsive IL-17 producing cells and closely resemble enthesitis associated murine Vγ6 γδT-cells. This data suggests that in humans the Vδ2 subset of γδT-cells are most likely to participate in SpA pathogenesis.


Disclosure: R. Cuthbert, None; E. M. Fragkakis, None; C. Bridgewood, None; R. Dunsmuir, None; A. Watad, None; A. Rao, None; A. Khan, None; H. Marzo-Ortega, Janssen, 2,Abbvie, Celgene, Janssen, Lilly, Novartis, UCB, 5,Abbvie, Celgene, Lilly, Novartis, UCB, 6; D. Newton, None; D. McGonagle, Novartis, Janssen, Pfizer, AbbVie, 2,Novartis, Janssen, Pfizer, AbbVie, 8.

To cite this abstract in AMA style:

Cuthbert R, Fragkakis EM, Bridgewood C, Dunsmuir R, Watad A, Rao A, Khan A, Marzo-Ortega H, Newton D, McGonagle D. The Vδ2 Subset of Γδt-Cells Are Present at Healthy Human Enthesis and Have Transcriptional and Functional Characteristics Consistent with a Capacity for IL- 17A Production in Response to IL-23 [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-v%ce%b42-subset-of-%ce%b3%ce%b4t-cells-are-present-at-healthy-human-enthesis-and-have-transcriptional-and-functional-characteristics-consistent-with-a-capacity-for-il-17a-production-in-response-t/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-v%ce%b42-subset-of-%ce%b3%ce%b4t-cells-are-present-at-healthy-human-enthesis-and-have-transcriptional-and-functional-characteristics-consistent-with-a-capacity-for-il-17a-production-in-response-t/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology